332 related articles for article (PubMed ID: 18021915)
1. Genetics and smoking cessation improving outcomes in smokers at risk.
Lerman CE; Schnoll RA; Munafò MR
Am J Prev Med; 2007 Dec; 33(6 Suppl):S398-405. PubMed ID: 18021915
[TBL] [Abstract][Full Text] [Related]
2. Twenty-first century tobacco use: it is not just a risk factor anymore.
Khurana S; Batra V; Patkar AA; Leone FT
Respir Med; 2003 Apr; 97(4):295-301. PubMed ID: 12693789
[TBL] [Abstract][Full Text] [Related]
3. Molecular genetics of successful smoking cessation: convergent genome-wide association study results.
Uhl GR; Liu QR; Drgon T; Johnson C; Walther D; Rose JE; David SP; Niaura R; Lerman C
Arch Gen Psychiatry; 2008 Jun; 65(6):683-93. PubMed ID: 18519826
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetics and smoking cessation with nicotine replacement therapy.
Ray R; Schnoll RA; Lerman C
CNS Drugs; 2007; 21(7):525-33. PubMed ID: 17579497
[TBL] [Abstract][Full Text] [Related]
5. Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials.
Lerman C; Jepson C; Wileyto EP; Epstein LH; Rukstalis M; Patterson F; Kaufmann V; Restine S; Hawk L; Niaura R; Berrettini W
Neuropsychopharmacology; 2006 Jan; 31(1):231-42. PubMed ID: 16123753
[TBL] [Abstract][Full Text] [Related]
6. Pharmacotherapy for smoking cessation: current advances and research topics.
Raupach T; van Schayck CP
CNS Drugs; 2011 May; 25(5):371-82. PubMed ID: 21476609
[TBL] [Abstract][Full Text] [Related]
7. Smoker characteristics and smoking-cessation milestones.
Japuntich SJ; Leventhal AM; Piper ME; Bolt DM; Roberts LJ; Fiore MC; Baker TB
Am J Prev Med; 2011 Mar; 40(3):286-94. PubMed ID: 21335259
[TBL] [Abstract][Full Text] [Related]
8. A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders.
Evins AE; Culhane MA; Alpert JE; Pava J; Liese BS; Farabaugh A; Fava M
J Clin Psychopharmacol; 2008 Dec; 28(6):660-6. PubMed ID: 19011435
[TBL] [Abstract][Full Text] [Related]
9. Genetic variation in mu-opioid-receptor-interacting proteins and smoking cessation in a nicotine replacement therapy trial.
Ray R; Jepson C; Wileyto EP; Dahl JP; Patterson F; Rukstalis M; Pinto A; Berrettini W; Lerman C
Nicotine Tob Res; 2007 Nov; 9(11):1237-41. PubMed ID: 17978999
[TBL] [Abstract][Full Text] [Related]
10. Drugs for tobacco dependence.
Treat Guidel Med Lett; 2008 Sep; 6(73):61-6. PubMed ID: 18719526
[No Abstract] [Full Text] [Related]
11. Non-nicotinic therapies for smoking cessation.
Siu EC; Tyndale RF
Annu Rev Pharmacol Toxicol; 2007; 47():541-64. PubMed ID: 17209799
[TBL] [Abstract][Full Text] [Related]
12. [Drug treatment of tobacco dependence].
Friederich HM; Batra A
Dtsch Med Wochenschr; 2009 Nov; 134(47):2402-5. PubMed ID: 19911331
[No Abstract] [Full Text] [Related]
13. Systematic review and meta-analysis of combination therapy for smoking cessation.
Shah SD; Wilken LA; Winkler SR; Lin SJ
J Am Pharm Assoc (2003); 2008; 48(5):659-65. PubMed ID: 18826906
[TBL] [Abstract][Full Text] [Related]
14. Pathways to precision medicine in smoking cessation treatments.
Chen LS; Horton A; Bierut L
Neurosci Lett; 2018 Mar; 669():83-92. PubMed ID: 27208830
[TBL] [Abstract][Full Text] [Related]
15. Physician barriers to incorporating pharmacogenetic treatment strategies for nicotine dependence into clinical practice.
Schnoll RA; Shields AE
Clin Pharmacol Ther; 2011 Mar; 89(3):345-7. PubMed ID: 21326262
[TBL] [Abstract][Full Text] [Related]
16. Implications of gene-drug interactions in smoking cessation for improving the prevention of chronic degenerative diseases.
Quaak M; van Schayck CP; Knaapen AM; van Schooten FJ
Mutat Res; 2009 Jul; 667(1-2):44-57. PubMed ID: 19028511
[TBL] [Abstract][Full Text] [Related]
17. Pharmacotherapy and pharmacogenetics of nicotine dependence.
Berrettini WH; Lerman CE
Am J Psychiatry; 2005 Aug; 162(8):1441-51. PubMed ID: 16055765
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial.
Aubin HJ; Lebargy F; Berlin I; Bidaut-Mazel C; Chemali-Hudry J; Lagrue G
Addiction; 2004 Sep; 99(9):1206-18. PubMed ID: 15317642
[TBL] [Abstract][Full Text] [Related]
19. Sex heterogeneity in pharmacogenetic smoking cessation clinical trials.
Schnoll RA; Patterson F
Drug Alcohol Depend; 2009 Oct; 104 Suppl 1(Suppl 1):S94-9. PubMed ID: 19135319
[TBL] [Abstract][Full Text] [Related]
20. [Current and future medical drugs for smoking cessation].
Kusma B; Mache S; Deissenrieder F; Quarcoo D; Welte T; Groneberg D
Laryngorhinootologie; 2009 Jun; 88(6):410-9; quiz 420-2. PubMed ID: 19504411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
